MAPT and Alzheimer disease: To investigate whether 43D monoclonal antibody can block AD p-Tau seeding and inhibit the spread of templated host Tau inclusions in 3 × Tg-AD mice, we immunized mice with six weekly intravenous doses of 43D or as a control with mouse IgG.